SC
Scribe Therapeutics Inc
SCTX
NASDAQ
Biotechnology
$20.73
USD
+0.36 (+1.77%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $0
Volume 118.9K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
SCTX | Scribe Therapeutics Inc | - | - | - | - | |
OCGN | Ocugen Inc | $457.80M | - | +0.4% | - | |
EDIT | Editas Medicine Inc | $441.54M | - | +20.8% | - | |
FENC | Fennec Pharmaceuticals Inc | $420.32M | - | +33.8% | - | |
LRMR | Larimar Therapeutics Inc | $416.57M | - | - | - | |
CCCC | C4 Therapeutics, Inc | $400.25M | - | -12.4% | - | |
UPB | Upstream Bio Inc | $397.81M | - | +13.2% | - | |
ENTA | Enanta Pharmaceuticals Inc | $392.56M | - | +7.4% | - | |
ABEO | Abeona Therapeutics Inc | $363.91M | 5.50 | - | - | |
STRO | Sutro Biopharma Inc | $360.08M | - | +49.9% | - |
Top Peer by Growth
TriSalus Life Sciences Inc
+39.6% YoY Revenue
Lowest P/E Ratio
Agenus Inc
4.88x P/E
Best 1-Year Return
Opus Genetics Inc
+238.2% Return